Trexquant Investment LP Seagen Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $5.28 Million - $7.03 Million	39,038 New	39,038 $5.34 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $498,056 - $657,287	-4,164 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $593,661 - $794,741	4,164 New	4,164 $644,000
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $1.21 Million - $1.44 Million	-8,924 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $329,336 - $456,966	-2,395 Reduced 21.16%	8,924 $1.24 Million

Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $1.86 Million - $2.4 Million	11,319 New	11,319 $1.98 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.